Claim Missing Document
Check
Articles

Found 2 Documents
Search

Analysis Factors Of Affecting Community Stigma With Covid-19 Patient Based On Health Belief Model Theory Kustin Kustin; Tolak Haris
Jurnal Kesehatan dr. Soebandi Vol 9 No 2 (2021): Jurnal Kesehatan dr. Soebandi
Publisher : LPPM Universitas dr. Soebandi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36858/jkds.v9i2.277

Abstract

Introduction: The stigma that exists in society views people with COVID-19 as people who are avoided, the feared disease is very contagious so that stigma causes anxiety and prejudice against sufferers. Objective : To analyze the factors that influence the stigma of society in patients with COVID-19 based on the Health Belief Model (HBM) theory. Methods: Descriptive correlation using a cross-sectional approach. The research sample was 150 respondents with accidental sampling design. The independent variables of this study were knowledge, beliefs and perceptions of threat. The dependent variable was stigma. Data were collected using a questionnaire. Data analysis used multiple regression statistical test with a significance degree of <0.05 (5%). Results: knowledge does not have a significant effect on beliefs (vulnerabilities, advantages, barriers, self-confidence with > 0.05. Knowledge variable has an effect on seriousness > 0.037. Confidence also does not have a significant effect on the threat of vulnerability (1,000), seriousness > 0.999, advantage > 1,000, barriers > 1,000 and belief has an effect on self-confidence > 0.000. For the threat variable does not have a significant effect on stigma > 0.996. Conclusion: The stigma against Covid-19 patients is the perception of seriousness and the perception of threats to Covid-19 patients who are felt to threaten the community to be infected with the virus. Lack of information is a trigger for the stigma of society towards Covid-19 patients.
The Patch Formulation of Rambusa (Passiflora foetida) Leave Extract as Anti-Inflammatory Agent: An In Vitro and In Vivo Study Setyaningrum, Lindawati; Aliyah Purwanti; Widaddhiya Zahra Anggraini; Adelia Royan Suryani; Tolak Haris; Lubis Nuril Ubaidilla
Jurnal Kesehatan dr. Soebandi Vol 12 No 1 (2024): Jurnal Kesehatan dr. Soebandi
Publisher : Lembaga Penelitian dan Pengabdian Masyarakat Universitas dr. Soebandi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36858/jkds.v12i1.712

Abstract

Rambusa leaves are known to have health benefits, including anti-inflammatory, antitumor, anticancer, antihepatotoxicity and antimicrobial. Rambusa leaves contain active compounds including alkaloids, tannins, saponins, and steroids which have anti-inflammatory effects. So it was developed as a transdermal route preparation in the form of a patch to overcome the problem of side effects from using oral medications on the gastrointestinal tract. Rambusa leaves are formulated into additional ingredients in the form of HPMC, methyl paraben, propylene glycol, 96% ethanol, distilled water and made into ready-to-use patches. Furthermore, an evaluation of the physical quality of the formula was carried out and its anti-inflammatory effectiveness was determined through in vitro and in vivo tests. The results show that each formula produces physical properties that meet the requirements. Apart from that, the results of the in vitro test using sodium diclofenac as a standard show that formulas 100, 200 and 300 are able to penetrate the membrane from the results of the cumulative amount of active ingredients that have been tested, whereas in the in vivo test using wistar rat test, the results of % edema were analyzed using ANOVA and the results of % inhibition were carried out in a post hoc test with LSD. The highest effectiveness was obtained in formula 300, this shows that the formula is capable of inhibiting inflammation. From these results it can be concluded that rambusa leave extract can be developed into a transdermal patch formula for anti-inflammation.